MCID: RHM035
MIFTS: 39

Rheumatic Fever-Related Antigen

Categories: Bone diseases, Rare diseases

Aliases & Classifications for Rheumatic Fever-Related Antigen

MalaCards integrated aliases for Rheumatic Fever-Related Antigen:

Name: Rheumatic Fever-Related Antigen 57
Rheumatic Fever 59 73
Acute Rheumatic Fever 59

Characteristics:

Orphanet epidemiological data:

59
rheumatic fever
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe),1-5/10000 (Canada),1-5/10000 (Spain),>1/1000 (Australia),1-5/10000 (India),>1/1000 (Mexico),1-9/100000 (Latin America),1-9/100000 (New Zealand); Age of onset: Childhood; Age of death: adult;

OMIM:

57
Inheritance:
? autosomal recessive


Classifications:



External Ids:

OMIM 57 268240
Orphanet 59 ORPHA3099
ICD10 via Orphanet 34 I00 I01.0 I01.1 more
MESH via Orphanet 45 D012213
UMLS via Orphanet 74 C0035436
SNOMED-CT via HPO 69 386661006 50177009

Summaries for Rheumatic Fever-Related Antigen

MalaCards based summary : Rheumatic Fever-Related Antigen, also known as rheumatic fever, is related to rheumatic fever and sydenham chorea. The drugs Adalimumab and Antirheumatic Agents have been mentioned in the context of this disorder. Affiliated tissues include heart, b cells and bone, and related phenotypes are fever and gait disturbance

Description from OMIM: 268240

Related Diseases for Rheumatic Fever-Related Antigen

Diseases related to Rheumatic Fever-Related Antigen via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 102)
# Related Disease Score Top Affiliating Genes
1 rheumatic fever 12.7
2 sydenham chorea 11.8
3 rheumatic myocarditis 11.6
4 acute articular rheumatism 11.6
5 aortic valve disease 2 11.3
6 rheumatic encephalitis 11.1
7 choreatic disease 11.0
8 heart disease 10.7
9 rheumatic heart disease 10.7
10 arthritis 10.4
11 endocarditis 10.3
12 pharyngitis 10.2
13 glomerulonephritis 10.2
14 reactive arthritis 10.2
15 scarlet fever 10.2
16 kawasaki disease 10.2
17 acute poststreptococcal glomerulonephritis 10.1
18 atrial standstill 1 10.0
19 aging 10.0
20 subacute bacterial endocarditis 10.0
21 antiphospholipid syndrome 10.0
22 atrioventricular block 10.0
23 infective endocarditis 10.0
24 pulmonary edema 10.0
25 purpura 10.0
26 streptococcal group a invasive disease 10.0
27 systemic lupus erythematosus 9.9
28 septic arthritis 9.9
29 myocarditis 9.9
30 collagen disease 9.9
31 lupus erythematosus 9.9
32 rheumatoid arthritis 9.8
33 osteomyelitis 9.8
34 tonsillitis 9.8
35 fiedler's myocarditis 9.8
36 cardiac tamponade 9.8
37 pericarditis 9.8
38 ischemia 9.8
39 pyoderma 9.8
40 syncope 9.8
41 autoimmune disease 9.7
42 gilles de la tourette syndrome 9.7
43 noonan syndrome 1 9.7
44 tetralogy of fallot 9.7
45 takayasu arteritis 9.7
46 heart block, congenital 9.7
47 familial mediterranean fever 9.7
48 orthostatic intolerance 9.7
49 anxiety 9.7
50 autoimmune disease 1 9.7

Graphical network of the top 20 diseases related to Rheumatic Fever-Related Antigen:



Diseases related to Rheumatic Fever-Related Antigen

Symptoms & Phenotypes for Rheumatic Fever-Related Antigen

Symptoms via clinical synopsis from OMIM:

57
Immunology:
predisposition to rheumatic fever

Lab:
increased frequency of b cells with 883 antigen


Clinical features from OMIM:

268240

Human phenotypes related to Rheumatic Fever-Related Antigen:

59 32 (show all 37)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 fever 59 32 Frequent (79-30%) HP:0001945
2 gait disturbance 59 Occasional (29-5%)
3 nausea and vomiting 59 Very frequent (99-80%)
4 constipation 59 Occasional (29-5%)
5 chorea 59 Frequent (79-30%)
6 respiratory insufficiency 59 Occasional (29-5%)
7 neurological speech impairment 59 Occasional (29-5%)
8 behavioral abnormality 59 Occasional (29-5%)
9 arthritis 59 Very frequent (99-80%)
10 fatigue 59 Frequent (79-30%)
11 subcutaneous nodule 59 Very frequent (99-80%)
12 arthralgia 59 Frequent (79-30%)
13 arrhythmia 59 Frequent (79-30%)
14 pallor 59 Frequent (79-30%)
15 abdominal pain 59 Frequent (79-30%)
16 aplasia/hypoplasia of the abdominal wall musculature 59 Occasional (29-5%)
17 sinusitis 59 Frequent (79-30%)
18 abnormality of the heart valves 59 Occasional (29-5%)
19 abnormality of the aortic valve 59 Frequent (79-30%)
20 abnormality of the pleura 59 Occasional (29-5%)
21 nephrotic syndrome 59 Occasional (29-5%)
22 anorexia 59 Very frequent (99-80%)
23 migraine 59 Occasional (29-5%)
24 abnormality of the immune system 32 HP:0002715
25 chest pain 59 Frequent (79-30%)
26 erythema 59 Occasional (29-5%)
27 epistaxis 59 Occasional (29-5%)
28 abnormality of the mitral valve 59 Frequent (79-30%)
29 pericarditis 59 Occasional (29-5%)
30 fasciculations 59 Occasional (29-5%)
31 dyslexia 59 Occasional (29-5%)
32 dysgraphia 59 Occasional (29-5%)
33 macule 59 Very frequent (99-80%)
34 myocarditis 59 Frequent (79-30%)
35 hemiballismus 59 Occasional (29-5%)
36 endocarditis 59 Frequent (79-30%)
37 recurrent pharyngitis 59 Frequent (79-30%)

Drugs & Therapeutics for Rheumatic Fever-Related Antigen

Drugs for Rheumatic Fever-Related Antigen (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 135)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Adalimumab Approved Phase 4 331731-18-1 16219006
2 Antirheumatic Agents Phase 4,Phase 3
3 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2
4
Methotrexate Approved Phase 3 1959-05-2, 59-05-2 126941
5
Etanercept Approved, Investigational Phase 3 185243-69-0
6
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
7
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
8
rituximab Approved Phase 3,Not Applicable 174722-31-7 10201696
9
Azathioprine Approved Phase 3 446-86-6 2265
10
chloroquine Approved, Investigational, Vet_approved Phase 3 54-05-7 2719
11
Hydroxychloroquine Approved Phase 3 118-42-3 3652
12
Leflunomide Approved, Investigational Phase 3 75706-12-6 3899
13
Sulfasalazine Approved Phase 3 599-79-1 5353980 5359476
14
Hyaluronic acid Approved, Vet_approved Phase 3 9004-61-9 53477741
15
Triamcinolone Approved, Vet_approved Phase 3 124-94-7 31307
16
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
17
Rivaroxaban Approved Phase 3 366789-02-8
18
Warfarin Approved Phase 3 81-81-2 6691 54678486
19
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
20
leucovorin Approved, Nutraceutical Phase 3 58-05-9 143 6006
21
Menadione Approved, Nutraceutical Phase 3 58-27-5 4055
22
Phytonadione Approved, Investigational, Nutraceutical Phase 3 84-80-0 4812 5284607
23
Serine Approved, Nutraceutical Phase 3 56-45-1 5951
24 Antimetabolites Phase 3,Not Applicable
25 Antimetabolites, Antineoplastic Phase 3
26 Dermatologic Agents Phase 3
27 Folic Acid Antagonists Phase 3
28 Immunosuppressive Agents Phase 3
29 Nucleic Acid Synthesis Inhibitors Phase 3
30 Vitamin B Complex Phase 3
31 Analgesics Phase 3
32 Analgesics, Non-Narcotic Phase 3
33 Anti-Inflammatory Agents, Non-Steroidal Phase 3
34 Gastrointestinal Agents Phase 3,Phase 2
35 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1
36 Natriuretic Peptide, Brain Phase 2, Phase 3
37 Antiemetics Phase 3,Phase 2
38 Antineoplastic Agents, Hormonal Phase 3,Phase 2
39 Autonomic Agents Phase 3,Phase 2,Phase 1
40 glucocorticoids Phase 3,Phase 2
41 Hematinics Phase 3
42 Hormone Antagonists Phase 3,Phase 2
43 Hormones Phase 3,Phase 2
44 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2
45 Methylprednisolone acetate Phase 3
46 Methylprednisolone Hemisuccinate Phase 3
47 Micronutrients Phase 3
48 Neuroprotective Agents Phase 3
49 Prednisolone acetate Phase 3
50 Prednisolone hemisuccinate Phase 3

Interventional clinical trials:

(show top 50) (show all 61)
# Name Status NCT ID Phase Drugs
1 A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis Completed NCT01119859 Phase 4 Tocilizumab;Adalimumab;Placebo to tocilizumab;Placebo to adalimumab
2 Erosive Osteoarthritis of the Hands: Treatment by Methotrexate Versus Placebo Unknown status NCT01068405 Phase 3 Methotrexate;Placebo
3 Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)? Completed NCT02164214 Phase 3 etanercept Treatment
4 A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis Completed NCT01007435 Phase 3 Tocilizumab;Placebo to tocilizumab;Methotrexate;Placebo to methotrexate
5 Mobile Health in Structural Heart Disease Completed NCT02881398 Phase 2, Phase 3
6 A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate Completed NCT00578305 Phase 3 Placebo;Methylprednisolone;Methotrexate;Folic acid or folate
7 A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis Completed NCT01232569 Phase 3 Tocilizumab 162 mg;Placebo
8 A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies Completed NCT02097745 Phase 3 methotrexate;rituximab [MabThera/Rituxan]
9 A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis Completed NCT00721123 Phase 3 Tocilizumab
10 An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies Completed NCT00720798 Phase 3 Tocilizumab;Disease-modifying anti-rheumatic drugs;Non-steroidal anti-inflammatory drugs;Oral corticosteroids
11 Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up Enrolling by invitation NCT03390036 Phase 3 Cingal;Triamcinolone Hexacetonide
12 INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority Not yet recruiting NCT02832544 Phase 3 Rivaroxaban (20 mg);Vitamin K antagonists (VKA)
13 INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority Not yet recruiting NCT02832531 Phase 3 Rivaroxaban (15 mg);Aspirin
14 Efficacy of Physiotherapy on the Health and Quality of Life of the Rheumatic Patient Unknown status NCT02020668 Phase 2
15 Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup) Completed NCT00001359 Phase 2 Penicillin or Placebo
16 Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery Completed NCT01794884 Phase 2 Glutamine;Ringer's solution
17 N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement Completed NCT01704482 Phase 2 N-acetylcysteine;placebo
18 Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia Recruiting NCT03033199 Phase 2 Probiotic Agent;Dexamethasone
19 Determining the Impact of Penicillin in Latent RHD: The GOAL Trial Not yet recruiting NCT03346525 Phase 2 intramuscular benzathine penicillin G (BPG) prophylaxis
20 Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers Completed NCT01525147 Phase 1
21 Dental Anesthesia in Pregnant Women With Rheumatic Heart Disease Completed NCT00482573 Phase 1
22 Controlled Human Infection for Vaccination Against Streptococcus Pyogenes Recruiting NCT03361163 Phase 1
23 Efficacy of BLIS K12 as Preventive Measure for Rheumatic Children Unknown status NCT02407106 Not Applicable
24 Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments Unknown status NCT01642706
25 Development of Intervention Model for Osteoporosis and Fall Prevention in Taiwan Unknown status NCT01206491
26 The Prevalence of Rheumatic Heart Disease in School Children in Fiji Unknown status NCT00779662
27 Rheumatic Heart Disease Prevalence in Leon, Nicaragua Unknown status NCT00307112
28 Plasma Adiponectin Levels and Relations With Cytokines in Children With Acute Rheumatic Fever Completed NCT01886846
29 Hospital Based Incidence of Group A Streptococcal Disease in Fiji Completed NCT00264771
30 Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory Completed NCT00884728
31 Rheumatic Heart Disease in Peru: Prevalence and Cardiovascular Outcomes Among Schoolchildren Completed NCT02353663
32 Impact of a Telenursing Service on Satisfaction and Health Outcomes of Children With Inflammatory Rheumatic Diseases Completed NCT01511341 Not Applicable
33 Guided Self-Management Intervention Targeting Fatigue in Rheumatic Inflammatory Diseases Completed NCT03216616 Not Applicable
34 Surveillance of Streptococcal Infections in Children in India Completed NCT00342199
35 Etude 3000 ARTHROSES Symptomatic Knee and Hip Osteoarthritis Prevalence Survey Completed NCT01400529
36 Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial Liquid on Structural Alterations in Patients Diagnosed With Rheumatoid Arthritis in the Previous Two Years Completed NCT02894047
37 C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France Completed NCT02886689 TNF-alpha antagonist and other biotherapy
38 Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region Completed NCT02188862
39 Effect of Simvastatin on Cardiac Function Completed NCT01178710 Not Applicable Simvastatin
40 Effect of Rheumatic Heart Disease on Maternal and Fetal Outcomes Completed NCT03029117
41 Rheumatic Heart Disease Study in Lusaka Completed NCT02661763
42 Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement Completed NCT02474108 Not Applicable
43 DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease Completed NCT00264524 Not Applicable
44 Cardiovascular Risk and Chronic Inflammatory Rheumatism Recruiting NCT03187444 Not Applicable
45 Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism Recruiting NCT02926560
46 Prospective Follow-up of Patients With Chronic Inflammatory Rheumatism Recruiting NCT03076866
47 Rheumatic Heart Disease School Project Recruiting NCT01550068
48 The Genetic Basis of Acquired Heart Disease in Africa Recruiting NCT02124109
49 RhEumatiC Heart diseAse Genetics Recruiting NCT02118818
50 Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology Outpatients Recruiting NCT03306784

Search NIH Clinical Center for Rheumatic Fever-Related Antigen

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Genetic Tests for Rheumatic Fever-Related Antigen

Anatomical Context for Rheumatic Fever-Related Antigen

MalaCards organs/tissues related to Rheumatic Fever-Related Antigen:

41
Heart, B Cells, Bone, Skin, Brain, Monocytes, T Cells

Publications for Rheumatic Fever-Related Antigen

Articles related to Rheumatic Fever-Related Antigen:

(show top 50) (show all 693)
# Title Authors Year
1
The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review. ( 29897915 )
2018
2
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study. ( 29653582 )
2018
3
Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children. ( 29442387 )
2018
4
Acute Rheumatic Fever, Kawasaki Disease or Alternative Diagnoses? A Call for the General Paediatrician. ( 29870101 )
2018
5
Acute rheumatic fever presenting as complete heart block: report of an adolescent case and review of literature. ( 29440244 )
2018
6
Predictive performance of six mortality risk scores and the development of a novel model in a prospective cohort of patients undergoing valve surgery secondary to rheumatic fever. ( 29979692 )
2018
7
Rheumatic fever - new diagnostic criteria. ( 29686441 )
2018
8
Acute Rheumatic Fever: Revised Diagnostic Criteria. ( 29851920 )
2018
9
Epidemiologic Impact of the New Guidelines for the Diagnosis of Acute Rheumatic Fever. ( 29605389 )
2018
10
Acute Rheumatic Fever: Revised Diagnostic Criteria. ( 29851921 )
2018
11
Aboriginal children and penicillin injections for rheumatic fever: how much of a problem is injection pain? ( 29168304 )
2018
12
The Jones Criteria for the Diagnosis of Acute Rheumatic Fever: Updated but Not Abandoned. ( 29709345 )
2018
13
Estimating the likely true changes in rheumatic fever incidence using two data sources. ( 29208066 )
2018
14
Delayed Diagnosis of Acute Rheumatic Fever in a Patient with Multiple Emergency Department Visits. ( 29974004 )
2018
15
Transition to adult care for Aboriginal children with rheumatic fever: a review informed by a focussed ethnography in northern Australia. ( 29310752 )
2018
16
Rheumatic fever: The rebound phenomenon returns. ( 29411467 )
2018
17
A Clear-cut Case of Acute Rheumatic Fever After Group G Streptococcal Pharyngitis in New Zealand. ( 29533349 )
2018
18
Rheumatic fever: update on the Jones criteria according to the American Heart Association review - 2015. ( 28743364 )
2017
19
Emm type distribution of group A streptococcus isolates from the throat swabs of children living in areas with a high (Northland and Gisborne) or low (Palmerston North) incidence of acute rheumatic fever. ( 28796768 )
2017
20
Using preceding hospital admissions to identify children at risk of developing acute rheumatic fever. ( 29168244 )
2017
21
Can We Eliminate Rheumatic Fever and Premature Deaths From RHD? ( 28552220 )
2017
22
Enablers and barriers to secondary prophylaxis for rheumatic fever among MA8ori aged 14-21 in New Zealand: a framework method study. ( 29149897 )
2017
23
The novel Group A Streptococcus antigen SpnA combined with bead-based immunoassay technology improves streptococcal serology for the diagnosis of acute rheumatic fever. ( 29269013 )
2017
24
Acute rheumatic fever: clinical profile in children in western Ukraine. ( 28616087 )
2017
25
Acute rheumatic fever and isolated myocarditis. ( 28560960 )
2017
26
Rheumatic fever as an indicator of child health. ( 28796766 )
2017
27
A retrospective study: Acute rheumatic fever and post-streptococcal reactive arthritis in Japan. ( 28442182 )
2017
28
MBL2 and FCN2 gene polymorphisms in a cohort of Italian children with rheumatic fever: A case-control study. ( 28576308 )
2017
29
Prescribing for people with acute rheumatic fever. ( 28507400 )
2017
30
WhA8nau perceptions and experiences of acute rheumatic fever diagnosis for MA8ori in Northland, New Zealand. ( 29121626 )
2017
31
Clinical management and patient persistence with antibiotic course in suspected group A streptococcal pharyngitis for primary prevention of rheumatic fever: the perspective from a New Zealand emergency department. ( 28617790 )
2017
32
Atrial fibrillation 50 years after acute rheumatic fever as the first manifestation of rheumatic mitral stenosis. ( 28405095 )
2017
33
Association of rheumatic fever & rheumatic heart disease with plausible early & late-stage disease markers. ( 29067978 )
2017
34
Rheumatic Fever Presenting as Recurrent Pericarditis and Cardiac Tamponade. ( 28720034 )
2017
35
Acute rheumatic fever and exposure to poor housing conditions in New Zealand: A descriptive study. ( 28052445 )
2017
36
Erratum in: Rheumatic Fever and Rheumatic Heart Disease a Historical Perspective. ( 28584595 )
2017
37
Clinical presentation and outcomes of patients with acute rheumatic fever and rheumatic heart disease seen at a tertiary hospital setting in Port Elizabeth, South Africa. ( 28430286 )
2017
38
Evaluation of vitamin D levels in patients with acute rheumatic fever. ( 28680013 )
2017
39
Childhood Blastic Plasmacytoid Dendritic Cell Neoplasm Mimicking Acute Rheumatic Fever: Report of an Unusual Clinical Presentation and Review of Literature. ( 28859047 )
2017
40
Acute rheumatic fever outbreak in southern central European country. ( 27815733 )
2017
41
Eliminating acute rheumatic fever and rheumatic heart disease. ( 28721865 )
2017
42
Atypical Articular Presentations in Indian Children with Rheumatic Fever. ( 28528779 )
2017
43
Penicillin Dried Blood Spot Assay for Use in Patients Receiving Intramuscular Benzathine Penicillin G and Other Penicillin Preparations To Prevent Rheumatic Fever. ( 28559267 )
2017
44
Ventricular dyssynchrony as a marker of latent carditis in children with acute rheumatic fever: A tissue Doppler imaging. ( 29067722 )
2017
45
Is a rheumatic fever register the best surveillance tool to evaluate rheumatic fever control in the Auckland region? ( 28796771 )
2017
46
Rheumatic Fever and Rheumatic Heart Disease a Historical Perspective. ( 27867464 )
2016
47
Association between rheumatic fever and Takayasu's arteritis - Case report. ( 27267532 )
2016
48
Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever. ( 27465618 )
2016
49
Tracking isolated myocarditis in a young adult with acute rheumatic fever on cardiac magnetic resonance imaging. ( 27526359 )
2016
50
2016 National Rheumatic Fever Week: The status of rheumatic heart disease in South Africa. ( 27499394 )
2016

Variations for Rheumatic Fever-Related Antigen

Expression for Rheumatic Fever-Related Antigen

Search GEO for disease gene expression data for Rheumatic Fever-Related Antigen.

Pathways for Rheumatic Fever-Related Antigen

GO Terms for Rheumatic Fever-Related Antigen

Sources for Rheumatic Fever-Related Antigen

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....